Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.24% | 30.09% | 37.65% | 44.25% | 46.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.24% | 30.09% | 37.65% | 44.25% | 46.76% |
| Cost of Revenue | 17.62% | 45.49% | 53.59% | 56.05% | 53.49% |
| Gross Profit | -18.25% | -20.22% | -11.01% | 8.32% | 25.49% |
| SG&A Expenses | -11.04% | -16.26% | -22.37% | -10.06% | 10.24% |
| Depreciation & Amortization | -8.67% | -4.09% | 4.47% | 23.37% | 51.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.22% | 32.73% | 36.83% | 41.95% | 45.66% |
| Operating Income | -116.44% | -103.59% | 205.09% | 557.92% | 184.12% |
| Income Before Tax | 16.40% | 68.86% | 47.02% | 46.75% | 10.37% |
| Income Tax Expenses | 97.54% | 98.42% | 79.69% | 82.49% | 81.72% |
| Earnings from Continuing Operations | 1.25% | 45.49% | 20.60% | -17.14% | -231.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.25% | 45.49% | 20.60% | -17.14% | -226.48% |
| EBIT | -116.44% | -103.59% | 205.09% | 557.92% | 184.12% |
| EBITDA | -3.96% | 0.24% | 25.81% | 82.46% | 97.73% |
| EPS Basic | 2.63% | 36.14% | 10.93% | -32.47% | -224.72% |
| Normalized Basic EPS | -2,978.95% | 69.00% | 103.40% | 112.64% | 97.93% |
| EPS Diluted | 2.63% | 36.14% | 10.94% | -32.00% | -222.63% |
| Normalized Diluted EPS | -2,978.95% | 69.00% | 103.40% | 112.82% | 97.90% |
| Average Basic Shares Outstanding | 1.91% | 3.10% | 6.06% | 9.79% | 14.85% |
| Average Diluted Shares Outstanding | 1.91% | 3.10% | 6.06% | 8.74% | 13.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.02% | -0.96% | -0.89% | -1.04% | -0.70% |